Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Test material form:
- solid: flakes
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source of test material: Clariant Plastics & Coatings (Deutschland) GmbH, BU Additives
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories,UK,Ltd
- Females (if applicable) nulliparous and non-pregnant: [yes]
- Age at study initiation: 9 to 11 weeks
- Weight at study initiation: 19.0 to 22.4 grams
- Housing: Animals were housed individually (to avoid licking of test item by cage mates) in solid floor standard polysulfone cages (Size: Approximately L 360 x B 205 x H 140 mm), with stainless steel top grill having facilities for providing pelletted food and drinking water in polycarbonate bottle with stainless steel sipper tubes. Steam sterilized corn cob was used as bedding and changed along with the cage once a week. Cages were placed on tiered racks. Mouse huts were provided in the cages as environment enrichment to minimize animal stress and promote overall well-being during the in-life phase of the study.
- Diet (e.g. ad libitum): The experimental animals were provided ad libitum Teklad Certified (2014C) Global 14% Protein Rodent Maintenance Diet-Pellet (Certified) manufactured by Envigo, P.O. Box 44220, Madison, WI 53744-4220
- Water (e.g. ad libitum): Deep bore-well water passed through activated charcoal filter and exposed to UV rays in Aquaguard on-line water filter-cum-purifier (manufactured by Eureka Forbes Ltd., Mumbai - 400 001, India).
- Acclimation period: 04 October 2018 to 09 October 2018
- Indication of any skin lesions: No
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 23°C
- Humidity (%): 59 to 67 per centy
- Air changes (per hr): 13.9 air changes/hour
- Photoperiod (hrs dark / hrs light): 12 hours light and 12 hours darkness
- IN-LIFE DATES: From: 10 October 2018 To: 15 October 2018
Study design: in vivo (LLNA)
- Vehicle:
- methyl ethyl ketone
- Concentration:
- The required quantity of the test item was mixed with MEK to get stock concentration of 60% w/v. The required volume of stock formulation was mixed with MEK to get dose formulations concentrations of 15 and 30% w/v.
- No. of animals per dose:
- 6 females per group
- Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: The current Guideline recommends vehicles/solvents such as acetone/olive oil (4:1 v/v), N,N-dimethylformamide (DMF), methyl ethyl ketone (MEK), propylene glycol (PG), dimethyl sulfoxide (DMSO) or 1% Pluronic® L92.
The miscibility / solubility of the test item was tested using AOO, DMF, MEK, PG, DMSO and 1% L92.
The test item is solid. Based on the maximum soluble concentration, MEK was selected as the vehicle
- Irritation: A concentration of 60% w/v was the maximum soluble concentration in Methyl ethyl ketone (MEK). Hence the highest possible dose concentration of 60% w/v in MEK was selected as highest dose concentration for testing.
Prior to the LLNA main study, the vehicle MEK and concentrations of 5, 10, 30, 45 and 60% w/v of the test item in MEK were evaluated for irritation potential as measured by erythema of the ears.
- Ear thickness measurements: Yes
- Erythema scores: Yes
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: The purpose of this Local Lymph Node Assay (LLNA) was to assess the potential of the test item to cause contact sensitization via measurement of lymph node proliferation following topical application of the test item to the dermal surfaces of the mouse ear.
- Criteria used to consider a positive response: The sensitizing potential was subsequently determined by the magnitude of the lymphocyte proliferative response in the auricular lymph nodes draining the ears. A test item that elicits a stimulation index [SI of >3 (i.e., 3-fold greater proliferation than vehicle control treated animals)] should be considered positive for a dermal sensitization potential.
TREATMENT PREPARATION AND ADMINISTRATION:
The application of the test item (25 µL/ear) was made on the dorsum of both ears as described above. Six female mice/group received the vehicle (MEK, or the positive control substance (25% v/v α-hexylcinnamaldehyde), or 15, 30 and 60 w/v test item in MEK, once daily for three consecutive days. Ears were inspected and skin reactions were evaluated prior to each application of the test item and on day 6. All mice were weighed on days 1 and 6. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- A mean dpm value ± SD (standard deviation) was calculated for each group and the stimulation index (SI) was calculated using the absolute dpm value for each mouse as the numerator, and the mean dpm value from the vehicle-treated mice as the denominator.
1. The % increase in ear thickness was calculated for each ear using the following equation:
% Ear swelling = ((B – A)/A) x 100
Where, A = ear thickness measurement on Day 1 (µm); B = ear thickness measurement on Day 3 or 6 (µm)
2. The SI was calculated for each mouse using the following equation:
SI = Disintegrations per minute (dpm) of individual mouse / Average dpm of the vehicle control mice
Mean and SD were generated for body weight data (absolute and gain) and LLNA response (dpm and SI values). The body weight and dpm data were analysed by one-way analysis of variance. When the differences were indicated by the ANOVA, a comparison of treated vs. control groups was done using a Dunnett’s t-test (p<0.05).
Statistically significant differences (p<0.05), indicated by the aforementioned tests, are designated by the superscripts throughout the report as stated below:
+/- : Significantly higher (+)/lower (-) than the vehicle control group
Results and discussion
- Positive control results:
- The sensitivity of this LLNA test was demonstrated via the response from the positive control (25% HCA in MEK), which elicited a stimulation index (SI) of 12.33, in comparison with the vehicle-treated mice.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.54
- Test group / Remarks:
- 15 % test substance
- Key result
- Parameter:
- SI
- Value:
- 1.68
- Test group / Remarks:
- 30 % test substance
- Key result
- Parameter:
- SI
- Value:
- 1.78
- Test group / Remarks:
- 60 % test substance
- Cellular proliferation data / Observations:
-
DETAILS ON STIMULATION INDEX CALCULATION : Since the test item Licocare RBW 300 FL TP produced Stimulation Index (SI) < 3, it is considered “Negative” for skin sensitization, and therefore an EC3 value was not determined.
CLINICAL OBSERVATIONS: There were no clinical signs, no erythema at the site of application
BODY WEIGHTS There were no significant effect on body weight gains
Any other information on results incl. tables
TABLE 1. Summary of Body Weight, body weight changesand clinical signs
|
|
|
|
|||
Group and Dose concentration
|
No. of mice |
|
Body weight (g) |
|||
Day 1 (Initial)
|
Day 6 |
Weight change (day 6 – Initial) |
Clinical signs |
|||
G1 Vehicle : MEK |
6 |
|
|
|
|
|
Mean |
20.70 |
21.35 |
0.65 |
NAD |
||
SD |
1.18 |
1.16 |
0.08 |
|||
|
|
|
|
|
||
G2 25% v/v HCA |
6 |
|
|
|
|
|
Mean |
20.70 |
21.33 |
0.63 |
NAD |
||
SD |
1.03 |
0.97 |
0.08 |
|||
|
|
|
|
|
||
G3 15% w/v test item |
6 |
|
|
|
|
|
Mean |
20.72 |
21.33 |
0.62 |
NAD |
||
SD |
1.02 |
1.06 |
0.08 |
|||
|
|
|
|
|
||
G4 30% w/v test item |
6 |
|
|
|
|
|
Mean |
20.65 |
21.25 |
0.60 |
NAD |
||
SD |
0.87 |
0.82 |
0.06 |
|||
|
|
|
|
|
||
G5 60% w/v test item |
6 |
|
|
|
|
|
Mean |
20.78 |
21.40 |
0.62 |
NAD |
||
SD |
0.96 |
0.99 |
0.04 |
|||
|
|
|
|
|
MEK: Methyl ethyl ketone
NAD : No Abnormality Detected
HCA : α –Hexylcinnamaldehyde
TABLE 2. Summaryof Local Reaction Scores at the Site of Application
Group and Dose concentration
|
No. of Mice |
|
Erythema Score of both ears (Mean ± SD) |
|||
Pre-treatment |
Day 2 |
Day 3 |
Day 6 |
|||
G1 Vehicle : MEK |
6 |
Mean SD |
0 0 |
0 0 |
0 0 |
0 0 |
G2 25% v/v HCA |
6 |
Mean SD |
0 0 |
0.83 0.41 |
1.00 0.00 |
1.00 0.00 |
G3 15% w/v test item |
6 |
Mean SD |
0 0 |
0 0 |
0 0 |
0 0 |
G4 30% w/v test item |
6 |
Mean SD |
0 0 |
0 0 |
0 0 |
0 0 |
G5 60% w/v test item |
6 |
Mean SD |
0 0 |
0 0 |
0 0 |
0 0 |
MEK: Methyl ethyl ketone
NAD: No Abnormality Detected
HCA :α–Hexylcinnamaldehyde
TABLE 3. Summary of Disintegrations Per Minute (DPM) for3H-Methyl Thymidine Incorporation in Auricular Lymph Nodes and Stimulation Index (SI)
|
|
|
||
Group and Dose concentration
|
No. of mice |
|
DPM / Mouse
|
SI
|
G1 Vehicle: MEK |
6 |
|
|
|
Mean |
923.50 |
1.00 |
||
SD |
116.41 |
0.13 |
||
|
|
|
||
G2 25% v/v HCA |
6 |
|
+ |
|
Mean |
11391.33 |
12.33 |
||
SD |
1832.36 |
1.98 |
||
|
|
|
||
G3 15% w/v test item |
6 |
|
+ |
|
Mean |
1427.50 |
1.54 |
||
SD |
210.01 |
0.23 |
||
|
|
|
||
G4 30% w/v test item |
6 |
|
+ |
|
Mean |
1547.50 |
1.68 |
||
SD |
360.28 |
0.39 |
||
|
|
|
||
G5 60% w/v test item |
6 |
|
+ |
|
Mean |
1644.67 |
1.78 |
||
SD |
472.81 |
0.51 |
||
|
|
|
+: Significantly higher than the vehicle control group
MEK: Methyl ethyl ketone
HCA :α –Hexylcinnamaldehyde
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- A topical application with 15, 30 and 60% w/v Licocare RBW 300 FL TP in Methyl ethyl ketone elicited a stimulation index (SI) of 1.54, 1.68 and 1.78, respectively. The test item Licocare RBW 300 FL TP did not demonstrate dermal sensitization potential in the mouse LLNA, as the lymph nodes draining the area of topical application did not elicit a proliferative response greater than the 3X threshold.
- Executive summary:
This Local Lymph Node Assay (LLNA) was conducted to evaluate the potential of the test item Licocare RBW 300 FL TP to cause contact sensitization by measuring the lymphocyte proliferative response from auricular lymph nodes following topical application to the female CBA/Ca mouse ear.
Screening Study: Oncedaily topicalapplication of the vehicleMethyl ethyl ketone (MEK) and 5, 10, 30, 45 and 60% w/vLicocare RBW 300 FL TP in MEKwere performed to one animal at each dose level. There were no clinical signs, no erythema at the site of application, no significant increase in the ear thickness and ear punch weights and no effect on body weight. The results of this screening test were used to determine the dosing concentration for the main study.
LLNA main study: Six female CBA/Ca mice/group received the vehicle (MEK) or 25% α-hexylcinnamaldehyde (HCA: positive control in MEK) or15, 30 and 60% w/vLicocare RBW 300 FL TP in MEK on days 1 to 3. On day 6, the uptake of3H-methyl thymidine into the auricular lymph nodes draining the site of test item application was measured five hours post administration. Proper conduct of the LLNA was confirmed via a positive response using 25% α-hexylcinnamaldehyde, a contact sensitizer, which elicited proliferation with a Stimulation Index (SI) value of 12.33, in comparison to vehicle-treated mice.
There were no clinical signs, no local skin reactions at the tested concentrations and treatment had no significant effect on body weight gain.
The test item Licocare RBW 300 FL TP at dose concentrations of15, 30 and 60% elicited proliferative response with SI of 1.54, 1.68 and 1.78, respectively in comparison with the vehicle-treated mice.
The test item Licocare RBW 300 FL TP did not demonstrate dermal sensitization potential in the mouse LLNA, as the lymph nodes draining the area of topical application did not elicit a proliferative response greater than the 3X threshold.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Għalkemm l-ECHA qiegħda tipprovdi ħafna materjal fil-lingwa tiegħek onlajn, parti minn din il-paġna qiegħda bl-Ingliż biss. Sir af aktar dwar il-prattika multilingwa tal-ECHA.
Merħba fuq is-sit web tal-ECHA. Dan is-sit mhux appoġġat b'mod sħiħ fl-Internet Explorer 7 (u l-verżjonijiet aktar bikrin). Jekk jogħġbok aġġorna l-Internet Explorer tiegħek għal verżjoni aktar ġdida.
Dan is-sit web juża l-cookies biex jiżgura li jkollok l-aqwa esperjenza fuq is-siti web tagħna.
Sir af aktar dwar kif nużaw il-cookies.